WHO ICTRP trial

Efficacy of 15 cc/hr perfusion rate in Ventricular-Lumbar Perfusuion therapy for…

KCT0001222 · Clinical Research Information Service (CRIS) · Recruiting

Key facts

Trial ID KCT0001222
Public title Efficacy of 15 cc/hr perfusion rate in Ventricular-Lumbar Perfusuion therapy for letomenigeal carcinomatosis; phase 2 study
Scientific title Efficacy of 15 cc/hr perfusion rate in Ventricular-Lumbar Perfusuion therapy for letomenigeal carcinomatosis; phase 2 study
Primary sponsor NCC Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Recruiting
Study type Interventional Study
Phase Phase2
Countries Korea, Republic of
Conditions Neoplasms
Interventions Drug : Treatment Plan : 1) Day 0: We evaluate patient’s symptoms related to leptomeningeal carcinomatosis(LMC). 2) Lumbar drainage is carried out 2 hours before intraventricular infusion for constant cerebrospinal fluid(CSF) flow. 3) Day…
Registration date Sep 15, 2014
Target size 49
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations